Cablivi

Product Specs	Cablivi
Manufacturer Name	Sanofi
Indications	CABLIVI (caplacizumab-yhdp) is a prescription medicine used for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Contraindications	Do not take CABLIVI if you’ve had an allergic reaction to caplacizumab-yhdp or to any of the ingredients in CABLIVI.
Manufacturing Methods	Recombinant DNA technology
Viral Safety Process
Route of Administration	Intravenous or subcutaneous use
Product Half-Life	The half-life of CABLIVI is concentration and target-level dependent.
Storage Requirements/Shelf Life	Store refrigerated at 2°C to 8°C (36°F to 46°F) in original package to protect from light. Do not freeze. Unopened vials may be stored in the original package at room temperature up to 30°C (86°F) up to 2 months. Do not return to the refrigerator after it has been stored at room temperature.
Available Formulations	11 mg/1 mL